Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LEAHRN (Late Effects After High-Risk Neuroblastoma) Study

NCT03057626 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT03057626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03057626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LEAHRN (Late Effects After High-Risk Neuroblastoma) Study
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Active, not recruiting
Start date
June 5, 2017
Completion date
September 30, 2026
Enrollment
376 (actual)
Sites
98

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent neuroblastoma, stage 2a neuroblastoma, stage 2b neuroblastoma, stage 3 neuroblastoma, stage 4 neuroblastoma, stage 4s neuroblastoma